 Acquired immunodeficiency syndrome Cerebrospinal fluid findings patients long-term oral zidovudine therapy Fifty-two patients acquired immunodeficiency syndrome study relationship cerebrospinal fluid CSF zidovudine concentrations neurologic human immunodeficiency virus HIV culture findings HIV-CSF culture neurologic measurements available patients Twenty-nine patients assessable zidovudine CSF concentrations Patients underwent lumbar puncture neurologic testing weeks oral zidovudine therapy mg/d weeks therapy frequency HIV isolation CSF cultures unchanged Significant neurologic improvement examination patients median CSF zidovudine concentration patients mg/L range mg/L correlation CSF zidovudine concentration cumulative dose HIV isolation CSF persistence resolution neurologic symptoms signs mechanisms zidovudine neurologic function unclear unrelated direct clearance virus CSF